New Era of Scientific Insight in the Prevention & Treatment of Viral Diseases
Virology is a branch of science that mainly deals with the study of the biology of viruses and viral diseases and mainly focuses on viral classification, biochemistry, physiology, molecular biology, ecology, evolution and clinical aspects of viruses. Past few years the world has been witnessing some of the chronic issues involving viruses like HIV, HPV and this is challenging researchers with some of the most recent outbreaks like EBOLA, Zika, and coronavirus. This clearly stipulates that the world of virologists should become more active and updated. Viruses also cause chronic diseases in plants and livestock. Viruses can infect all life-forms. Viruses are small Pathogens, subcellular Pathogens that are unable to multiply outside a host cell. Viruses differ from microorganisms in their extreme dependence on the host cell.
Vaccines play a key role in the healthcare department, especially for growing children. Vaccines are products that protect people against chronic diseases. Unlike other medicines that treat or cure diseases, vaccines prevent them. Vaccines are products that generate immunity to a specific disease. Vaccines play a major role in keeping us healthy. Totally 26 Vaccines are available authorized by the World Health Organization. Vaccination is the most effective method of preventing infectious and chronic diseases.
There are 4 main types of vaccines:
Emerging Infectious Diseases:
Emerging infectious diseases are infections that have recently come into sight within a population or the occurrence range is rapidly increasing or threatens to increase in the near future. The WHO warned in its report that Infectious diseases are emerging at a frequency that has not been seen before.
Emerging infectious diseases can be caused by:
- Previously undetected or unknown infection-causing agents
- Known infection-causing agents that have widely spread to new geographic locations or new populations
- Previously known infection-causing agents whose role in specific diseases has previously gone unidentified.
Open access planning to release a year end special issue has announced almost 50% discount on article publication charges to celebrate its journey for publishing articles with in the short time.
A standard editorial manager system is utilized for manuscript submission, review, editorial processing and tracking which can be securely accessed by the authors, reviewers and editors for monitoring and tracking the article processing.
Manuscripts can be forwarded to the Editorial Office at email@example.com
How we work:
- After submission, an acknowledgement with manuscript number is sent to the corresponding author within 7 working days.
- A 21 day window time frame is allotted for peer-review process wherein multiple experts are contacted.
- Author proof is generated within 7 working days after the acceptance decision.
Benefits on Publication:
Open Access: Permanent free access to your article upon publication ensures extensive global reach and readership.
Easy Article Sharing: Our open access enables you to share your article directly with colleagues through email and on social media via a single link, permitting third party reuse with appropriate citation in addition to the retention of content copyright by the author.
Global Marketing: Through promotion in a targeted global email announcement or press release, your article will be seen by thousands of the top-most thought-leaders in your field.
Color Art: In a world of black & white journal articles, high-quality full-color images make your article stand out from the crowd and tell a complete story, increasing readers and citations.
Social Media Exposure: Extended reach for your article through links on Twitter accounts provides maximum visibility worldwide.
Reprints: Distribute your work to colleagues and at conferences as we provide hard copy color reprints of your article on order.
Journal of Vaccines & Vaccination